Home » Authors » Holland Johnson

Articles by Holland Johnson

Merck among pharmas eyeing new device/diagnostic sectors

Nov. 17, 2005

By Holland Johnson

Deals roundup: Varian's buy of Polymer Labs is valued at up to $65 million

Nov. 10, 2005

By Holland Johnson

Gingrich: U.S. healthcare must undergo ‘profound’ changes

Oct. 27, 2005

By Holland Johnson

OraSure OTC HIV test will be 1st to go before an FDA panel

Oct. 20, 2005

By Holland Johnson

Genzyme unveils targeted test to aid in treatment of NSCLC

Oct. 6, 2005

By Holland Johnson

Study: Computerized errors on ECGs are commonplace

Oct. 1, 2005

By Holland Johnson

New HF guidelines emphasize early diagnosis, treatment

Oct. 1, 2005

By Holland Johnson

Two September weeks show cardiovascular sector’s vitality

Oct. 1, 2005

By Holland Johnson

Study finds that computerized errors on ECGs are common

Sep. 22, 2005

By Holland Johnson

APNS submits pre-IDE for AD test as first step toward okay

Sep. 15, 2005

By Holland Johnson

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...